Nuvation Bio: Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst
Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
Seeking Alpha24d
NUVB Nuvation Bio Inc.
Nuvation Bio Inc. (NUVB) stock price is 2.50 and Nuvation Bio Inc. (NUVB) 10-day simple moving average is 2.62. Nuvation Bio Inc. (NUVB) stock price is 2.50 and Nuvation Bio Inc. (NUVB ...
Business Insider28d
Nuvation Bio price target raised to $11 from $10 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Nuvation Bio (NUVB) to $11 from $10 and keeps a Buy rating on the shares. The firm sees additional upside in taletrectinib. Published first on ...
Business Insider1mon
Buy Rating on Nuvation Bio: Promising Taletrectinib Results and Strong Valuation Support $7 Target
Nuvation Bio (NUVB – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert Burns from H.C. Wainwright reiterated a Buy rating on the stock ...